Daily Market Movement: Alto Ingredients Inc (ALTO) Sees a -5.58% Decrease, Closing at $2.37

Nora Barnes

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The closing price of Alto Ingredients Inc (NASDAQ: ALTO) was $2.37 for the day, down -5.58% from the previous closing price of $2.51. In other words, the price has decreased by -$5.58 from its previous closing price. On the day, 1.75 million shares were traded. ALTO stock price reached its highest trading level at $2.558 during the session, while it also had its lowest trading level at $2.33.

Ratios:

Our analysis of ALTO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 3.56. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.52.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 13 ’25 when Sneed James R bought 3,176 shares for $1.06 per share. The transaction valued at 3,364 led to the insider holds 432,397 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALTO now has a Market Capitalization of 183432544 and an Enterprise Value of 281309888. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20 while its Price-to-Book (P/B) ratio in mrq is 0.82. Its current Enterprise Value per Revenue stands at 0.305 whereas that against EBITDA is 17.47.

Stock Price History:

The Beta on a monthly basis for ALTO is 0.55, which has changed by 0.6733333 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, ALTO has reached a high of $2.92, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 51.00%, while the 200-Day Moving Average is calculated to be 93.96%.

Shares Statistics:

ALTO traded an average of 1.34M shares per day over the past three months and 1607700 shares per day over the past ten days. A total of 77.34M shares are outstanding, with a floating share count of 67.51M. Insiders hold about 12.71% of the company’s shares, while institutions hold 27.46% stake in the company. Shares short for ALTO as of 1763078400 were 992450 with a Short Ratio of 0.74, compared to 1760486400 on 439590. Therefore, it implies a Short% of Shares Outstanding of 992450 and a Short% of Float of 1.35.

Earnings Estimates

A comprehensive evaluation of Alto Ingredients Inc (ALTO) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.12.

Analysts are recommending an EPS of between -$0.18 and -$0.18 for the fiscal current year, implying an average EPS of -$0.18. EPS for the following year is -$0.25, with 1.0 analysts recommending between -$0.25 and -$0.25.

Revenue Estimates

It is expected that $90B in revenue will be generated in. The current quarter, according to 2 analysts. It ranges from a high estimate of $253.36M to a low estimate of $216.3M. As of. The current estimate, Alto Ingredients Inc’s year-ago sales were $236.35MFor the next quarter, 2 analysts are estimating revenue of $210.4M. There is a high estimate of $210.4M for the next quarter, whereas the lowest estimate is $210.4M.

A total of 2 analysts have provided revenue estimates for ALTO’s current fiscal year. The highest revenue estimate was $939.32M, while the lowest revenue estimate was $902.3M, resulting in an average revenue estimate of $920.81M. In the same quarter a year ago, actual revenue was $965.26MBased on 2 analysts’ estimates, the company’s revenue will be $994.99M in the next fiscal year. The high estimate is $1.04B and the low estimate is $952M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.